| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 4 | 6 | 3 | 12 | 3 | 4 | 3 | 3 | 8 | 6 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 9.87 | 227.81 | 1,227.97 | 2,473.56 |
| Receivables | — | — | — | 1.98 |
| Inventory | — | — | — | — |
| Other | 4.33 | 4.13 | 25.80 | 45.37 |
| 14.20 | 231.94 | 1,253.77 | 2,520.91 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 2.27 | 2.97 | 4.15 | 10.47 |
| ST’ Debt | — | — | — | — |
| Other | 2.16 | — | — | 2.50 |
| 3.20 | 5.34 | 25.55 | 52.02 |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | ‡‡‡ |
| Earnings | — | — | ‡‡‡ |
| Book Value | — | — | ‡‡‡ |
| Year |
|---|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (17.87) | (47.59) | — | — |
—
|
| ’25 | (12.24) | (18.47) | (18.03) | (33.43) |
(82.17)
|
| ’24 | (7.29) | (9.75) | (7.88) | (13.47) |
(38.39)
|
| ’23 | (0.68) | (6.14) | (3.55) | (5.62) |
(16.00)
|
| ’22 | (0.15) | (0.16) | (0.44) | (0.21) |
(0.95)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (50.68) | (141.68) | — | — |
—
|
| ’25 | (12.57) | (19.35) | (23.08) | (60.38) |
(115.38)
|
| ’24 | (7.38) | (9.83) | (7.99) | (13.54) |
(38.74)
|
| ’23 | (0.68) | (6.17) | (3.59) | (5.65) |
(16.08)
|
| ’22 | (0.15) | (0.16) | (0.44) | (0.21) |
(0.95)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.19) | (0.28) | — | — |
—
|
| ’25 | (0.07) | (0.18) | (0.20) | (0.27) |
(0.72)
|
| ’24 | 0.05 | 0.06 | 0.04 | (0.09) |
(0.74)
|
| ’22 | (0.01) | 0.00 | 0.02 | 0.04 |
0.06
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | ‡‡‡ | 9.60 | 9.91 | 5.35 | 17.42 | — | — | — |
Low Price
|
| — | — | — | — | — | ‡‡‡‡‡ | 9.93 | 10.80 | 28.12 | 193.84 | — | — | — |
High Price
|
| — | — | — | — | — | ‡‡‡ | 0 | 0 | 113 | 205 | — | — | — |
Employees
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Gross Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | 5.40 | (32.17) | (72.93) | (110.19) | — | — | — |
EBT
|
| — | — | — | — | — | ‡‡‡ | 0.00% | 0.00% | 0.00% | 0.00% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| — | ‡‡‡ | — | — | — | ‡‡‡‡‡ | 3.93 | (32.17) | (73.62) | (105.66) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| — | — | — | — | — | — | — | 0.08 | (0.25) | (2.96) | — | — | — |
Depreciation
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.08 | 0.26 | (0.74) | (0.72) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.07) | (0.23) | (0.39) | (0.56) | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.00 | (0.23) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.07) | (0.23) | (0.39) | (0.79) | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.99) | (0.50) | 2.54 | 10.09 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 13.95 | 68.89 | 98.91 | 146.35 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
PE Ratio
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
EV/Sales
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
EV/FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.95) | (16.00) | (38.39) | (82.17) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | — | — | (0.08) | (0.35) | (33.20) | ‡‡‡‡‡ | — | — |
Capex
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.95) | (16.08) | (38.74) | (115.38) | — | — | — |
FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | 2.51 | 11.00 | 226.60 | 1,228.22 | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Total Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | (3.58) | (9.87) | (227.81) | (1,227.97) | — | — | — |
Net Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | (13.80) | (34.36) | 250.86 | 1,476.21 | — | — | — |
Sh' Equity
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.77% | (12.26%) | (49.64%) | (11.67%) | — | — | — |
ROA
|
| — | — | — | — | — | ‡‡‡ | 0.00% | 0.00% | (143.21%) | (35.07%) | — | — | — |
ROIC
|
| — | — | — | — | — | ‡‡‡ | (29.09%) | 133.60% | (68.01%) | (12.24%) | — | — | — |
ROE
|
Oklo Inc. (OKLO) is pioneering the nuclear energy revival with small modular reactors (SMRs) tailored for AI data centers’ insatiable power needs, backed by OpenAI’s Sam Altman and propelled by a 2024 SPAC debut. Despite pre-revenue status and deepening losses—projected at -$89 million in 2025 amid R&D burn and massive dilution—the company boasts a cash-rich balance sheet ($227 million working capital) and employee growth signaling commercialization ramp-up, with modest $16 million revenue forecasted from 2025 onward. Stock price has rocketed over 500% from IPO levels, decoupling from weak fundamentals on nuclear hype, permitting wins, and macro tailwinds like AI energy surges and policy support.
Insider selling dominates via post-lockup 10b5-1 plans, totaling over $500 million led by founders, but aligns with profit-taking after explosive gains while retaining significant stakes. Analysts are bullish, with price targets implying 32-166% upside, pricing in hypergrowth far beyond flat revenue forecasts via EV/Sales multiples exceeding 600x, betting on Oklo’s waste-recycling fast reactors as first-mover for 24/7 baseload power.
Execution risks like regulatory delays loom, but zero debt, ADVANCE Act streamlining, and hyperscaler partnerships position Oklo for 2027 deployments and positive free cash flow. In an AI world doubling power demand by 2026, OKLO offers multi-bagger disruption potential—fundamentals lag, but momentum and conviction scream upside.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.